Owner Sosei R&D Ltd.

Inventors Bannister, Robin Mark; Richards, Andrew John McGlashan; Gilbert, Julian Clive; Morton, David A.; Staniforth, John

Agent Dark IP

Pub. Number AU-B-2010200660

Parent 2004242450

Filing date 23 February 2010

Wipo publication date 11 March 2010

Acceptance publication date 19 April 2012

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61L 9/04 (2006.01) Disinfection, sterilisation or deodorisation of air - using substances evaporated in the air without heating

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups